Document is current
Any future updates will be listed below
-
Authors
Wang, Hui http://orcid.org/0000-0003-1494-6668
Remke, Marianne
Horn, Thomas
Schwamborn, Kristina
Chen, Yiyao
Steiger, Katja
Weichert, Wilko
Wester, Hans-Jürgen
Schottelius, Margret
Weber, Wolfgang A.
Eiber, Matthias
-
Funding
Funding for this research was provided by:
DFG Sonderforschungsbereich 824 (Project B11, Project Z2)
China Scholarship Council
Klinikum rechts der Isar der Technischen Universität München
- License Information
-
More Information
Article History
Received: 14 July 2023
Accepted: 16 October 2023
First Online: 16 November 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the Declaration of Helsinki. All patients involved in the analysis have signed informed consent. This retrospective study has been approved by the Ethics Committee of the Technical University Munich (750/20 S-KH).
: Not applicable.
: Katja Steiger served as a speaker for Akoya Biosystems and 10X Genomics, is member of the advisory board of TRIMT GmbH and has filed a patent on a radiopharmaceutical. Wilko Weichert has attended Advisory Boards and served as speaker for Roche, MSD, BMS, AstraZeneca, Pfizer, Merck, Lilly, Boehringer, Novartis, Takeda, Bayer, Amgen, Astellas, Eisai, Illumina, Siemens, Agilent, ADC, GSK and Molecular Health. Margret Schottelius is the Associate Editor of EJNMMI Research. Wolfgang Weber is the Advisory Editor of EJNMMI Research. No potential conflict of interest related to this article was reported.
